Vaccines Manufacturing and Innovation Centre
TheVaccines Manufacturing and Innovation Centre(VMIC) is avaccineresearch and manufacturing facility under construction inHarwell Science and Innovation CampusinOxfordshire,England. Announced in December 2018[1]and originally planned to be opened in 2022,[2]its planned opening date has been brought forward to 2021 as a response to theCOVID-19 pandemic.[3]
Organizations collaborating in the centre's development includeImperial College London,theLondon School of Hygiene and Tropical Medicine,andOxford University.[2]The UK government provided funding of £93 million for the construction of the centre in 2020,[4]and by March 2021 total funding reached £215m.[5]
Construction of the 7,000 square metre facility atHarwellwas begun by main contractor Glencar in April 2020.[6]
In 2020, the centre's personnel contributed to development of theOxford–AstraZeneca COVID-19 vaccineAZD1222, and from October began medium-scale production.[7]
References
[edit]- ^"New vaccines centre to protect UK from pandemic threats".University of Oxford.3 December 2018.Retrieved22 March2021.
- ^ab"Vaccines Manufacturing Innovation Centre, Oxfordshire, UK".www.pharmaceutical-technology.com.Retrieved17 January2021.
- ^"Vaccines Manufacturing and Innovation Centre to open 12 months ahead of schedule".GOV.UK.Retrieved17 January2021.
- ^"Government invests £93 million in new vaccine-manufacturing facility".ITV News.17 May 2020.Retrieved17 January2021.
- ^"Extra £47.6 million for Vaccines Manufacturing and Innovation Centre".GOV.UK.20 March 2021.Retrieved21 March2021.
- ^Weinfass, Ian (21 April 2020)."Vaccine-production facility build fast-tracked".Construction News.Retrieved22 March2021.
- ^"2020 Review".VMIC.21 December 2020.Retrieved22 March2021.
External links
[edit]51°42′59″N1°12′58″W/ 51.7163889°N 1.2161111°W